Removal of diclofenac by conventional drinking water treatment processes and granular activated carbon filtration

Chemosphere

Volumn 92, Issue 2, 2013, Pages 184-191

  Rigobello, Eliane Sloboda ^a   Dantas, Angela Di Bernardo ^b   Di Bernardo, Luiz ^a   Vieira, Eny Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

Author keywords

Byproducts; Chlorine; Chlorine dioxide; Diclofenac; Drinking water treatment; Granular activated carbon

Indexed keywords

ACTIVATED CARBON; ACTIVATED CARBON TREATMENT; ALUMINUM SULFATE; BYPRODUCTS; CARBOXYLATION; CHEMICAL WATER TREATMENT; CHLORINE; GRANULAR MATERIALS; HYDROXYLATION; ORGANIC CARBON; OXIDATION; PHASE SEPARATION; POTABLE WATER; SULFUR COMPOUNDS; WATER FILTRATION;

AQUATIC HUMIC SUBSTANCES; CHLORINE DIOXIDES; CONVENTIONAL TREATMENTS; DICLOFENAC; DISSOLVED ORGANIC CARBON; DRINKING WATER TREATMENT PROCESS; GRANULAR ACTIVATED CARBON FILTRATION; GRANULAR ACTIVATED CARBONS;

CHEMICALS REMOVAL (WATER TREATMENT);

ACTIVATED CARBON; ALUMINUM SULFATE; CHLORINE DIOXIDE; DICLOFENAC; DRINKING WATER; KAOLIN; WELL WATER;

ACTIVATED CARBON; ARTESIAN WELL; CHLORINE; COAGULATION; DISINFECTION; DISSOLVED ORGANIC CARBON; DRINKING WATER; FILTRATION; KAOLIN; SEDIMENTATION; SUBSTITUTION; TURBIDITY; WATER TREATMENT;

ARTICLE; COLOR; DECARBOXYLATION; FILTRATION; FLOCCULATION; GRANULAR ACTIVATED CARBON FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMIC SUBSTANCE; HYDROXYLATION; QUANTITATIVE ANALYSIS; SAND; SEDIMENTATION; SOLID PHASE EXTRACTION; TURBIDITY; WATER TREATMENT;

EID: 84876862424     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2013.03.010     Document Type: Article

References (39)

1. ANVISA (National Agency of Sanitary Vigilance), 2003. Guides for Validation of Analytical Methods and Bioanalytical. Resolution - RE no. 899, May 29, 2003.
2. Bedding N.D., Mcintyre A.E., Perry R., Lester J.N. Organic contaminants in the aquatic environmental II. Behavior and fate in the hydrological cycle. Sci. Total Environ. 1983, 26:255-312.
3. Boleda M.R., Galceran M.T., Ventura F. Behavior of pharmaceuticals and drugs of abuse in a drinking water treatment plant (DWTP) using combined conventional and ultrafiltration and reverse osmosis (UF/RO) treatments. Environ. Pollut. 2011, 159:1584-1591.
4. Dabrowska A., Kasprzyk-Hordern B., Nawrocki J. Aldehydes formation during water disinfection by ozonation and chlorination process. Glob. Nest J. 2005, 7:61-71.
5. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
6. Hoigné J., Bader H. Kinetics of reactions of chlorine dioxide (OClO) in water - I. Rate constants for inorganic and organic compounds. Water Res. 1994, 28:45-55.
7. Huang Q., Yu Y., Tang C., Zhang K., Cui J., Peng X. Occurrence and behavior of non-steroidal anti-inflammatory drugs and lipid regulators in wastewater and urban river water of the Pearl River Delta, South China. J. Environ. Monit. 2011, 13:863-885.
8. Huber M.M., Korhonenb S., Ternes T.A., Gunten U.V. Oxidation of pharmaceuticals during water treatment with chlorine dioxide. Water Res. 2005, 39:3607-3617.
9. ICH (International Conference on Harmonisation), 1995. Validation of Analytical Procedures: Methodology, Q2B (CPMP/ICH/281/95).
10. Ikehata K., Naghashkar N.J., El-Din M.G. Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: a review. Ozone-Sci. Eng. 2006, 28:353-414.
11. Kim S.D., Cho J., Kim I.S., Vanderford B.J., Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking and waste waters. Water Res. 2007, 41:1013-1021.
12. Lapworth D.J., Baran N., Stuart M.E., Ward R.S. Emerging organic contaminants in groundwater: a review of sources, fate and occurrence. Environ. Pollut. 2012, 163:287-303.
13. Melo S.A.S., Trovó A.G., Bautitz I.R., Nogueira R.F.P. Degradação de fármacos residuais por processos oxidativos avançados. Quim. Nova 2009, 32:188-197.
14. Ministry of Health. Water Quality Norm for Human Consumption, 2004. Ordinance no. 518, March 25, 2004. (accessed 07.08). http://dtr2001.saude.gov.br/sas/PORTARIAS/Port2004/GM/GM-518.htm.
15. Ministry of Health. Water Quality Norm for Human Consumption, 2011. Ordinance no. 2914, December 12, 2011. (accessed 07.12). http://www.comitepcj.sp.gov.br/download/Portaria_MS_2914-11.pdf.
16. Miyamoto G., Zahid N., Uetrecht J.P. Oxidation of diclofenac to reactive intermediates by neutrophils, myeloperoxidase, and hypochlorous acid. Chem. Res. Toxicol. 1997, 10:414-419.
17. Montagner C.C., Jardim W.F. Spatial and seasonal variations of pharmaceuticals and endocrine disruptors in the Atibaia river, São Paulo state (Brazil). J. Braz. Chem. Soc. 2011, 22:1452-1462.
18. Morasch B., Bonvin F., Reiser H., Grandjean D., Alencastro L.F., Perazzolo C., Chèvre N., Kohn T. Occurrence and fate of micropollutants in the vidy bay of lake Geneva, Switzerland. Part II: micropollutant removal between wastewater and raw drinking water. Environ. Toxicol. Chem. 2010, 29:1658-1668.
19. Muttamara S., Sales C.I., Gazali Z. The formation of thihalomethanos from chemical disinfectants and humic substances in drinking water. Water Supply 1995, 13:105-117.
20. Pojana G., Fantinati A., Marcomini A. Occurrence of environmentally relevant pharmaceuticals in Italian drinking water treatment plants. Int. J. Environ. Anal. Chem. 2011, 91:537-552.
21. Quintana J.B., Rodil R., López-Mahía P., Muniategui-Lorenzo S., Prada-Rodriguez D. Investigating the chlorination of acidic pharmaceuticals and by-product formation aided by an experimental design methodology. Water Res. 2010, 44:243-255.
22. Quintana J.B., Weiss S., Reemtsma T. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res. 2005, 39:2654-2664.
23. Rabiet M., Togola A., Brissaud F., Seidel J.-L., Budzinski H., Elbaz-Poulichet F. Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized mediterranean catchment. Environ. Sci. Technol. 2006, 40:5282-5288.
24. Radjenovic J., Petrovic M., Ventura F., Barcelo D. Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment. Water Res. 2008, 42:3601-3619.
25. Rigobello E.S., Dantas A.D.B., Di Bernardo L., Vieira E.M. Influence of the apparent molecular size of aquatic humic substances on colour removal by coagulation and filtration. Environ. Technol. 2011, 32:1767-1777.
26. Rodil R., Quintana J.B., Concha-Graña E., López-Mahía P., Muniategui-Lorenzo S., Prada-Rodríguez D. Emerging pollutants in sewage, surface and drinking water in Galicia (NW Spain). Chemosphere 2012, 86:1040-1049.
27. Soufan M., Deborde M., Legube B. Aqueous chlorination of diclofenac: kinetic study and transformation products identification. Water Res. 2012, 46:3377-3386.
28. Steffen C., Wetzel E. Chlorate poisoning: mechanism of toxicity. Toxicology 1993, 84:217-231.
29. Ternes T.A., Meisenheimer M., McDowell D., Sacher F., Brauch H.-J., Haist-Gulde B., Preuss G., Wilme U., Zullei-Seibert N. Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 2002, 36:3855-3863.
30. Thurman E.M., Malcolm R.L. Preparative isolation of aquatic substances. Environ. Sci. Technol. 1981, 15:463-466.
31. Touraud E., Roig B., Sumpter J.P., Coetsier C. Drug residues and endocrine disruptors in drinking water: risk for humans?. Int. J. Hyg. Environ. Heal. 2011, 214:437-441.
32. USEPA (United States Environmental Protection Agency), 1999. Alternative Disinfectants and Oxidants Guindance Manual. Washington, 1999. 41, EPA 5-1.
33. Valcárcel Y., Alonso S.G., Rodríguez-Gil J.L., Gil A., Catalá M. Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk. Chemosphere 2011, 84:1336-1348.
34. Valcárcel Y., Alonso S.G., Rodríguez-Gil J.L., Maroto R.R., Gil A., Catalá M. Analysis of the presence of cardiovascular and analgesic/anti-inflammatory/antipyretic pharmaceuticals in river and drinking-water of the Madrid Region in Spain. Chemosphere 2011, 82:1062-1071.
35. Vieno N., Tuhkanen T., Kronberg L. Removal of pharmaceuticals in drinking water treatment: effect of chemical coagulation. Environ. Technol. 2010, 27:183-192.
36. Vieno N.M., Rarkki H., Tuhkanen T., Kronberg F. Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant. Environ. Sci. Technol. 2007, 41:5077-5084.
37. Vulliet E., Cren-Olive C., Grenier-Loustalot M.-F. Occurrence of pharmaceuticals and hormones in drinking water treated from surface waters. Environ. Chem. Lett. 2011, 9:102-114.
38. Zhang Y., Geißen S.U., Gal C. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 2008, 73:1151-1161.
39. Ziylan A., Ince N.H. The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: treatability by conventional and non-conventional processes. J. Hazard. Mater. 2011, 187:24-36.